• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Technology·MDB
Held by 3 Gurus
Share

MongoDB, Inc. Stocks

$ 368.74Last Updated 04.09.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 29.66B

$ 368.74
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.1%

Change

+0.01%

Fund

CITADEL ADVISORS LLC

Bob Prince, Greg Jensen, Karen Karniol-Tambour

Portfolio Weight (%)

0.1%

Change

-0.00%

Fund

Bridgewater Associates

Steven Cohen

Portfolio Weight (%)

0.1%

Change

-0.14%

Fund

Point72 Asset Management, L.P.

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.1%+0.01%
Bob Prince, Greg Jensen, Karen Karniol-TambourBridgewater Associates0.1%-0.00%
Steven CohenPoint72 Asset Management, L.P.0.1%-0.14%

Latest news

03.09.2026 15:26

Morning in New York: Speculation Over the Fed's Interest Rate Is Intensifying

02.09.2026 15:00

Morning in New York: September Began with Weakness in Stocks and Bonds

01.09.2026 15:33

Morning in New York: Oil and Interest Rates Are Once Again Putting Pressure on High-Priced Tech Stocks

17.07.2026 11:26

Software developers are under fire once again. Which companies in the sector are worth investing in?

18.06.2026 22:44

Nebius and Data Center Providers: Goldman Identifies the Beneficiaries of the “Cost Supercycle”

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

MongoDB, Inc. serves as a global provider of a versatile database platform. The company's offerings feature MongoDB Enterprise Advanced, a sophisticated commercial database server designed for corporate clients, which can be deployed in cloud, on-premises, or hybrid environments. It also presents MongoDB Atlas, a fully managed, multi-cloud database-as-a-service (DBaaS) solution. For developers seeking to start with MongoDB, the company offers a free, downloadable Community Server that includes fundamental database functionalities. Beyond its core database products, MongoDB, Inc. provides professional services such as consulting and training. Founded in 2007 and based in New York, New York, the company was formerly known as 10gen, Inc. before adopting the name MongoDB, Inc. in August 2013.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of MDB is 468 and suggests 26.9% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.09.2026 17:04

Novartis's failed trials sent shares of mid-cap biotech company Dyne plummeting. The two companies have similar drugs.

09.09.2026 16:15

The dollar has fallen to a seven-month low. What is driving it down?

09.09.2026 15:41

Morning in New York: Brent Puts Investors to the Test

09.09.2026 14:40

U.S. authorities criticized Ford for its business dealings with China. Its stock fell 4%.

09.09.2026 13:30

The owner of Calvin Klein is betting on two brands. Why does UBS have confidence in his stock?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026